The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts / Abboud, C; Berman, E; Cohen, A; Cortes, J; Deangelo, D; Deininger, M; Devine, S; Druker, B; Fathi, A; Jabbour, E; Jagasia, M; Kantarjian, H; Khoury, J; Laneuville, P; Larson, R; Lipton, J; Moore, Jo; Mughal, T; O'Brien, S; Pinilla-Ibarz, J; Quintas-Cardama, A; Radich, J; Reddy, V; Schiffer, C; Shah, N; Shami, P; Silver, Rt; Snyder, D; Stone, R; Talpaz, M; Tefferi, A; Van Etten, Ra; Wetzler, M; Abruzzese, E; Apperley, J; Breccia, M; Byrne, J; Cervantes, F; Chelysheva, E; Clark, Re; de Lavallade, H; Dyagil, I; Gambacorti-Passerini, C; Goldman, J; Haznedaroglu, I; Hjorth-Hansen, H; Holyoake, T; Huntly, B; le Coutre, P; Lomaia, E; Mahon, Fx; Marin-Costa, D; Martinelli, G; Mayer, J; Milojkovic, D; Olavarria, E; Porkka, K; Richter, J; Rousselot, P; Saglio, G; Saydam, G; Stentoft, J; Turkina, A; Vigneri, P; Zaritskey, A; Aguayo, A; Ayala, M; Bendit, I; Bengio, Rm; Best, C; Bullorsky, E; Cervera, E; Desouza, C; Fanilla, E; Gomez-Almaguer, D; Hamerschlak, N; Lopez, J; Magarinos, A; Meillon, L; Milone, J; Moiraghi, B; Pasquini, R; Pavlovsky, C; Ruiz-Arguelles, Gj; Spector, N; Arthur, C; Browett, P; Grigg, A; Hu, Jd; Huang, Xj; Hughes, T; Jiang, Q; Jootar, S; Kim, Dw; Malhotra, H; Malhotra, P; Matsumura, I; Melo, J; Ohnishi, K; Ohno, R; Saikia, T; Schwarer, Ap; Takahashi, N; Tam, C; Tauchi, T; Usuki, K; Wang, Jx; Abdel-Rahman, F; Aljurf, Mds; Bazarbachi, A; Ben Yehuda, D; Chaudhri, N; Durosinmi, M; Kamel, H; Louw, V; Francismatti, B; Nagler, A; Raanani, P; Salem, Z. - In: BLOOD. - ISSN 0006-4971. - 121:22(2013), pp. 4439-4442. [10.1182/blood-2013-03-490003]

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Breccia M;
2013

2013
01 Pubblicazione su rivista::01a Articolo in rivista
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts / Abboud, C; Berman, E; Cohen, A; Cortes, J; Deangelo, D; Deininger, M; Devine, S; Druker, B; Fathi, A; Jabbour, E; Jagasia, M; Kantarjian, H; Khoury, J; Laneuville, P; Larson, R; Lipton, J; Moore, Jo; Mughal, T; O'Brien, S; Pinilla-Ibarz, J; Quintas-Cardama, A; Radich, J; Reddy, V; Schiffer, C; Shah, N; Shami, P; Silver, Rt; Snyder, D; Stone, R; Talpaz, M; Tefferi, A; Van Etten, Ra; Wetzler, M; Abruzzese, E; Apperley, J; Breccia, M; Byrne, J; Cervantes, F; Chelysheva, E; Clark, Re; de Lavallade, H; Dyagil, I; Gambacorti-Passerini, C; Goldman, J; Haznedaroglu, I; Hjorth-Hansen, H; Holyoake, T; Huntly, B; le Coutre, P; Lomaia, E; Mahon, Fx; Marin-Costa, D; Martinelli, G; Mayer, J; Milojkovic, D; Olavarria, E; Porkka, K; Richter, J; Rousselot, P; Saglio, G; Saydam, G; Stentoft, J; Turkina, A; Vigneri, P; Zaritskey, A; Aguayo, A; Ayala, M; Bendit, I; Bengio, Rm; Best, C; Bullorsky, E; Cervera, E; Desouza, C; Fanilla, E; Gomez-Almaguer, D; Hamerschlak, N; Lopez, J; Magarinos, A; Meillon, L; Milone, J; Moiraghi, B; Pasquini, R; Pavlovsky, C; Ruiz-Arguelles, Gj; Spector, N; Arthur, C; Browett, P; Grigg, A; Hu, Jd; Huang, Xj; Hughes, T; Jiang, Q; Jootar, S; Kim, Dw; Malhotra, H; Malhotra, P; Matsumura, I; Melo, J; Ohnishi, K; Ohno, R; Saikia, T; Schwarer, Ap; Takahashi, N; Tam, C; Tauchi, T; Usuki, K; Wang, Jx; Abdel-Rahman, F; Aljurf, Mds; Bazarbachi, A; Ben Yehuda, D; Chaudhri, N; Durosinmi, M; Kamel, H; Louw, V; Francismatti, B; Nagler, A; Raanani, P; Salem, Z. - In: BLOOD. - ISSN 0006-4971. - 121:22(2013), pp. 4439-4442. [10.1182/blood-2013-03-490003]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1664013
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 494
  • ???jsp.display-item.citation.isi??? 368
social impact